Read More Pharma Industry News HKBU-led researchers develop EBV drug for nasopharyngeal cancer A research team headed by Hong Kong Baptist University (HKBU) claims to have developed a novel anti-Epstein-Barr virus… bypharmanewsdailyMay 12, 2020
